Buy This Undervalued Stock Before Everyone Else Does fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Author Bio
Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing. Follow @alexcarchidi
What s more exciting (to cannabis investors, at least) than growing a massive amount of marijuana? If you said, combining the holdings of two major cultivators to grow a truly
colossal amount of marijuana, you re probably already salivating over the merger between
Aphria (NASDAQ:APHA), set to happen later this year.
Author Bio
Adria Cimino grew up with her nose in a book and a love of storytelling. By a twist of fate, she started her career writing about biotech in Boston and discovered that each company is the source of many fascinating stories. Prior to joining The Fool as a contract writer focused on healthcare and consumer goods, Adria covered the stock market for Bloomberg News in Paris. When she’s not analyzing companies, she can be found writing fiction or trying to speak French as well as her 9-year-old daughter. Follow @adria in paris
Every 30 seconds, a surgeon uses
2 Green Flags and 2 Red Flags for Tilray and Aphria fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Shares of
Intuitive Surgical (NASDAQ:ISRG) are down more than 7% since the start of January. Investors apparently weren t thrilled with the company s fourth-quarter numbers, which came in Thursday evening, and the stock fell 6.84% on Friday.
The irony is the fourth quarter numbers were fairly positive. It was the first earnings period since the first quarter of 2020 during which the robotic-assisted surgery (RAS) company had better revenue than the year before.
Net revenue in the quarter was a reported $1.3 billion, a rise of 4% year over year, and net income was $365 million, compared to $358 million in the same quarter in 2019.
Image source: Getty Images.